PURPOSE: A pharmaceutical composition containing cilostazol and a ginkgo leaf extract for preventing or treating hearing loss is provided to suppress apoptosis of auditory cells caused by generation of reactive oxygen species (ROS) thereby effectively preventing or treating noise deafness or ototoxic deafness. CONSTITUTION: A pharmaceutical composition for preventing or treating hearing loss contains cilostazol and a gingko leaf extract as active ingredients which are mixed in a weight ratio of ...

AEROSOLIZED FOSFOMYCIN/AMINOGLYCOSIDE COMBINATION FOR THE TREATMENT OF BACTERIAL RESPIRATORY INFECTIONS Abstract Aerosol formulations are described for the prevention and treatment of infection caused by susceptible bacteria in the respiratory tract of a patient. The formulation comprises from about I mg to about 300 mg of fosfomycin and about I mg to about 300 mg of an aminoglycoside selected from the group of gentamicin, kanamycin B, amikacin, arbekacin, dibekacin, streptomycin, neomycin, and ...

Disclosed is a chewable antibiotic veterinary formulation comprising: an antibiotic, selected from group consisting of beta lactams, semisynthetic penicillins, bacitracin, cephalosporins, quinolones, fluorinated quinolones, polymyxin, tetracyclines, chloramphenicol, aminoglycosides, nalidixic acid, rifamycins, sulfonamides, amikacin, aminosalicyclic acid, amoxicillin, amoxicillin and clavulanate potassium, ampicillin, bacampicillin, bacitracin, capreomycin, carbenicillin, carbenicillin indanyl s...

PROBLEM TO BE SOLVED: To provide a coated antibiotic substance in a porous material capable of continuously releasing an antibiotic in a sustained-release manner in an aqueous environment for a period of several days to several weeks.SOLUTION: This coated antibiotic substance in the porous material is obtained by introducing the coated substance into a porous system of a nonmetallic porous material and/or another porous system of a metallic porous material wherein the coated substance is formed ...